Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

medullary thyroid gland carcinoma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent review highlights the relationship between C-cell lesions and medullary thyroid carcinoma, providing insights into their pathophysiology and potential implications for diagnosis and treatment. This comprehensive analysis may inform future research directions in thyroid cancer.

A recent publication explores synchronous medullary carcinoma of the pancreas alongside non-ampullary duodenal adenocarcinoma. This study contributes to the understanding of these rare cancer types and their potential interrelation.

Recent research highlights the role of targeted therapies in treating advanced medullary thyroid cancer, offering new insights into effective management strategies. This study emphasizes the potential for improved patient outcomes through personalized treatment approaches.

A recent study highlights the occurrence of calcified liver metastases in a patient with medullary thyroid carcinoma associated with Multiple Endocrine Neoplasia Type 2A. This research contributes to the understanding of metastatic patterns in this rare disease.

A recent review discusses the management strategies for medullary thyroid cancer, highlighting advancements in treatment approaches. The article provides insights into current practices and emerging therapies in the field.

Recent research identifies three novel concomitant NTRK2 fusions in medullary thyroid carcinoma, highlighting their potential diagnostic implications. This discovery may enhance understanding of the molecular underpinnings of this rare cancer.

Not rare diseases news,news about your rare disease.